Related references
Note: Only part of the references are listed.Attenuation of ongoing neuropathic pain by peripheral acting opioid involves activation of central dopaminergic neurocircuitry
Shivani Vaidya et al.
NEUROSCIENCE LETTERS (2021)
Protein-protein interaction inhibitor of SRPKs alters the splicing isoforms of VEGF and inhibits angiogenesis
Qingyun Li et al.
ISCIENCE (2021)
Tozasertib Attenuates Neuropathic Pain by Interfering with Aurora Kinase and KIF11 Mediated Nociception
Ankit Uniyal et al.
ACS CHEMICAL NEUROSCIENCE (2021)
Changes in vascular permeability in the spinal cord contribute to chemotherapy-induced neuropathic pain
Karli Montague-Cardoso et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Prevention of chemotherapy-induced peripheral neuropathy: A review of recent findings
Eiman Y. Ibrahim et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Role of VEGFs/VEGFR-1 Signaling and Its Inhibition in Modulating Tumor Invasion: Experimental Evidence in Different Metastatic Cancer Models
Claudia Ceci et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Activation of μ-δ opioid receptor heteromers inhibits neuropathic pain behavior in rodents
Vinod Tiwari et al.
PAIN (2020)
Debunking the Myth of the Endogenous Antiangiogenic Vegfaxxxb Transcripts
Hugues Dardente et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2020)
VEGF-A165b levels are reduced in breast cancer patients at primary diagnosis but increase after completion of cancer treatment
Maria Margarete Karsten et al.
SCIENTIFIC REPORTS (2020)
Decreased Ratio of VEGF165b/VEGF in Aqueous Humor Predicts Progression of Diabetic Retinopathy
Feng Jiang et al.
OPHTHALMIC RESEARCH (2020)
Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma
Pedro Miguel Lacal et al.
PHARMACOLOGICAL RESEARCH (2020)
VEGF165b and its mutant demonstrate immunomodulatory, not merely anti-angiogenic functions, in tumor-bearing mice
Zhang Huiyong et al.
MOLECULAR IMMUNOLOGY (2020)
VEGF in Signaling and Disease: Beyond Discovery and Development
Rajendra S. Apte et al.
CELL (2019)
Vascular Endothelial Growth Factor A Signaling Promotes Spinal Central Sensitization and Pain-related Behaviors in Female Rats with Bone Cancer
Xue-Ming Hu et al.
ANESTHESIOLOGY (2019)
Eruca sativa Meal against Diabetic Neuropathic Pain: An H2S-Mediated Effect of Glucoerucin
Elena Lucarini et al.
MOLECULES (2019)
The uses of naltrexone in dermatologic conditions
Brigette Lee et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
The Anti-Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo
Maria Grazia Atzori et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
Michael J. Curtis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2
Chloe J. Peach et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain
Katherine Stockstill et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
GDNF, Neurturin, and Artemin Activate and Sensitize Bone Afferent Neurons and Contribute to Inflammatory Bone Pain
Sara Nencini et al.
JOURNAL OF NEUROSCIENCE (2018)
Diabetes-induced microvascular complications at the level of the spinal cord: a contributing factor in diabetic neuropathic pain
N. Ved et al.
JOURNAL OF PHYSIOLOGY-LONDON (2018)
Adipose-derived stem cells decrease pain in a rat model of oxaliplatin-induced neuropathy: Role of VEGF-A modulation
Lorenzo Di Cesare Mannelli et al.
NEUROPHARMACOLOGY (2018)
Etiology and Pharmacology of Neuropathic Pain
Sascha R. A. Alles et al.
PHARMACOLOGICAL REVIEWS (2018)
Oxaliplatin-induced blood brain barrier loosening: a new point of view on chemotherapy-induced neurotoxicity
Jacopo Junio Valerio Branca et al.
Oncotarget (2018)
Modulation of VEGF-A Alternative Splicing as a Novel Treatment in Chronic Kidney Disease
Megan Stevens et al.
GENES (2018)
Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non-competitive inhibitors
Pedro Miguel Lacal et al.
PHARMACOLOGICAL RESEARCH (2018)
Hypoxia-inducible factor 1 protects peripheral sensory neurons from diabetic peripheral neuropathy by suppressing accumulation of reactive oxygen species.
Daniel Rangel Rojas et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2018)
The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells
Maria Grazia Atzori et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Effects of natural and synthetic isothiocyanate-based H2S-releasers against chemotherapy-induced neuropathic pain: Role of Kv7 potassium channels
Lorenzo Di Cesare Mannelli et al.
NEUROPHARMACOLOGY (2017)
Heterodimerisation between VEGFR-1 and VEGFR-2 and not the homodimers of VEGFR-1 inhibit VEGFR-2 activity
Meng Cai et al.
VASCULAR PHARMACOLOGY (2017)
Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain
John L. Hamilton et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Vascular endothelial growth factor: a neurovascular target in neurological diseases
Christian Lange et al.
NATURE REVIEWS NEUROLOGY (2016)
Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agents
Beverly L. Falcon et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding
Grazia Graziani et al.
ONCOTARGET (2016)
The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling
Noah A. Kolb et al.
JAMA NEUROLOGY (2016)
Spinal Plasticity and Behavior: BDNF-Induced Neuromodulation in Uninjured and Injured Spinal Cord
Sandra M. Garraway et al.
NEURAL PLASTICITY (2016)
Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions
Candice Chapouly et al.
BRAIN (2015)
A Functional Role for VEGFR1 Expressed in Peripheral Sensory Neurons in Cancer Pain
Deepitha Selvaraj et al.
CANCER CELL (2015)
Oxaliplatin evokes P2X7-dependent glutamate release in the cerebral cortex: A pain mechanism mediated by Pannexin 1
Lorenzo Di Cesare Mannelli et al.
NEUROPHARMACOLOGY (2015)
D-Aspartate Modulates Nociceptive-Specific Neuron Activity and Pain Threshold in Inflammatory and Neuropathic Pain Condition in Mice
Serena Boccella et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Chemotherapy-induced neuropathy: A comprehensive survey
N. C. Miltenburg et al.
CANCER TREATMENT REVIEWS (2014)
Serotonergic modulation in neuropathy induced by oxaliplatin: Effect on the 5HT2C receptor
Daniela Baptista-de-Souza et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Glial role in oxaliplatin-induced neuropathic pain
Lorenzo Di Cesare Mannelli et al.
EXPERIMENTAL NEUROLOGY (2014)
Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia
R. P. Hulse et al.
NEUROBIOLOGY OF DISEASE (2014)
Neutralization of Schwann Cell-Secreted VEGF Is Protective to In Vitro and In Vivo Experimental Diabetic Neuropathy
Michela M. Taiana et al.
PLOS ONE (2014)
VEGF-A165b Is an Endogenous Neuroprotective Splice Isoform of Vascular Endothelial Growth Factor A in Vivo and in Vitro
Nicholas Beazley-Long et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
New prospects in the roles of the C-terminal domains of VEGF-A and their cooperation for ligand binding, cellular signaling and vessels formation
Romain Delcombel et al.
ANGIOGENESIS (2013)
Delineating multiple functions of VEGF-A in the adult brain
Tamar Licht et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Morphologic Features and Glial Activation in Rat Oxaliplatin-Dependent Neuropathic Pain
Lorenzo Di Cesare Mannelli et al.
JOURNAL OF PAIN (2013)
Spatial regulation of VEGF receptor endocytosis in angiogenesis
Masanori Nakayama et al.
NATURE CELL BIOLOGY (2013)
THERAPEUTIC POTENTIAL OF VEGF AND VEGF-DERIVED PEPTIDE IN PERIPHERAL NEUROPATHIES
A. Verheyen et al.
NEUROSCIENCE (2013)
Systemic anti-vascular endothelial growth factor therapies induce a painful sensory neuropathy
An Verheyen et al.
BRAIN (2012)
Chemotherapy-induced peripheral neurotoxicity (CIPN): An update
Andreas A. Argyriou et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)
Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease
Azeb Tadesse Argaw et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Central administration of oxytocin reduces hyperalgesia in mice: Implication for cannabinoid and opioid systems
R. Russo et al.
PEPTIDES (2012)
The role of heterodimerization between VEGFR-1 and VEGFR-2 in the regulation of endothelial cell homeostasis
Melissa J. Cudmore et al.
NATURE COMMUNICATIONS (2012)
Tying the knot: The cystine signature and molecular-recognition processes of the vascular endothelial growth factor family of angiogenic cytokines
Shalini Iyer et al.
FEBS JOURNAL (2011)
Evolution of the VEGF-Regulated Vascular Network from a Neural Guidance System
Sreenivasan Ponnambalam et al.
MOLECULAR NEUROBIOLOGY (2011)
VEGF and its receptor-2 involved in neuropathic pain transmission mediated by P2X2/3 receptor of primary sensory neurons
Jiari Lin et al.
BRAIN RESEARCH BULLETIN (2010)
TRPA1 modulation of spontaneous and mechanically evoked firing of spinal neurons in uninjured, osteoarthritic, and inflamed rats
Steve McGaraughty et al.
MOLECULAR PAIN (2010)
Spinal antinociceptive effects of cyclooxygenase inhibition during inflammation: Involvement of prostaglandins and endocannabinoids
Alejandro Telleria-Diaz et al.
PAIN (2010)
Role and Therapeutic Potential of VEGF in the Nervous System
Carmen Ruiz De Almodovar et al.
PHYSIOLOGICAL REVIEWS (2009)
Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization
Harukiyo Kawamura et al.
BLOOD (2008)
The neuropathic pain triad: Neurons, immune cells and glia
Joachim Scholz et al.
NATURE NEUROSCIENCE (2007)
A guided tour into subcellular colocalization analysis in light microscopy
S. Bolte et al.
JOURNAL OF MICROSCOPY (2006)
A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2
S. Cebe Suarez et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1
HW Christinger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
VEGF165b, an inhibitory vascular endothelial growth factor splice variant:: Mechanism of action, in vivo effect on angiogenesis and endogenous protein expression
J Woolard et al.
CANCER RESEARCH (2004)
Changes in sensory processing in the spinal dorsal horn accompany vincristine-induced hyperalgesia and allodynia
HR Weng et al.
PAIN (2003)
Acetyl-l-carnitine induces muscarinic antinocieption in mice and rats
C Ghelardini et al.
NEUROPHARMACOLOGY (2002)
A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel
RC Polomano et al.
PAIN (2001)
Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy
P Schratzberger et al.
NATURE MEDICINE (2000)
Share Paper
